超声衰减成像无创评估儿童肝脂肪变性的诊断性能
ATI值与BMI、ALT、尿酸及NAFLD评分显著正相关,预测肝脂肪变性的能力优于其他无创NAFLD预测指标,观察者间和观察者内ICC分别为0.92、0.96和0.93。
要点
- ATI值在超重/肥胖组和脂肪变组显著高于正常体重组和无脂肪变组。
- ATI预测肝脂肪变性的ROC分析显示能力很好,且优于其他无创NAFLD预测模型。
- ATI观察者间ICC为0.92,观察者内ICC分别为0.96和0.93,重复性良好。
核心结论
- 超声衰减成像(ATI)是一种客观且可行的替代筛查方法,可用于检测肥胖儿童患者的肝脂肪变性。
研究设计与样本
- 使用超声扫描仪进行ATI检查,由两名放射科医生评估肝脂肪变分级和ATI值。
- 获取人体测量学和生化参数,计算NAFLD评分包括Framingham脂肪变指数(FSI)和肝脂肪变指数(HSI)。
关键影像表现/征象
- ATI值在超重/肥胖组显著高于正常体重组,在脂肪变组显著高于无脂肪变组。
- ATI值与BMI、血清丙氨酸转氨酶(ALT)、尿酸和NAFLD评分呈显著正相关(p < 0.05)。
- 在调整年龄、性别、BMI、ALT、尿酸和HSI的多重线性回归中,ATI与BMI和ALT呈显著正相关(p < 0.05)。
诊断标准与关键数值
- ROC分析显示ATI预测肝脂肪变性能力很好。
- 观察者间变异ICC为0.92,观察者内变异ICC分别为0.96和0.93(p < 0.05)。
- 两水平贝叶斯潜类别模型分析显示,ATI在已知无创NAFLD预测指标中预测肝脂肪变性表现最佳。
临床应用与阅片要点
- ATI可作为定量工具用于儿童肝脂肪变性的筛查,帮助临床医生估计病变程度并追踪随时间的变化。
- ATI有助于监测疾病进展和指导治疗决策,尤其在儿科实践中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic performance of attenuation imaging (ATI) with an ultrasound scanner (US) in the detection of paediatric hepatic steatosis.
METHODS: Ninety-four prospectively enrolled children were classified into normal weight and overweight/obese (OW/OB) groups according to body mass index (BMI). US findings, including hepatic steatosis grade and ATI value, were examined by two radiologists. Anthropometric and biochemical parameters were obtained, and nonalcoholic fatty liver disease (NAFLD) scores, including the Framingham steatosis index (FSI) and hepatic steatosis index (HSI), were calculated.
RESULTS: After screening, 49 OW/OB and 40 normal weight children aged 10-18 years old (55 males and 34 females) participated in this study. The ATI value was significantly higher in the OW/OB group than in the normal weight group and showed a significant positive correlation with BMI, serum alanine transferase (ALT), uric acid, and NAFLD scores (p < 0.05). In the multiple linear regression adjusted for age, sex, BMI, ALT, uric acid, and HSI, ATI showed a significant positive association with BMI and ALT (p < 0.05). The receiver operating characteristic analysis showed a very good ability of ATI to predict hepatic steatosis. The intraclass correlation coefficient (ICC) of interobserver variability was 0.92, and the ICCs of intraobserver variability were 0.96 and 0.93 (p < 0.05). According to the two-level Bayesian latent class model analysis, the diagnostic performance of ATI showed the best performance for predicting hepatic steatosis among other known noninvasive NAFLD predictors.
CONCLUSIONS: This study suggests that ATI is an objective and possible surrogate screening test for detecting hepatic steatosis in paediatric patients with obesity.
CLINICAL RELEVANCE STATEMENT: Using ATI as a quantitative tool in hepatic steatosis allows clinicians to estimate the extent of the condition and track changes over time. This is helpful for monitoring disease progression and guiding treatment decisions, especially in paediatric practice.
KEY POINTS: • Attenuation imaging is a noninvasive US-based method for the quantification of hepatic steatosis. • Attenuation imaging values were significantly higher in the OW/OB and steatosis groups than in the normal weight and no steatosis groups, respectively, with a meaningful correlation with known clinical indicators of nonalcoholic fatty liver disease. • Attenuation imaging performs better than other noninvasive predictive models used to diagnose hepatic steatosis.
引用
- Hwang, Cho. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging. Eur Radiol. 2023. PMID: 37195431. doi:10.1007/s00330-023-09731-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。